Skip to main content
Abpro Bio Co., Ltd. logo

Abpro Bio Co., Ltd. — Investor Relations & Filings

Ticker · 195990 ISIN · KR7195990007 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2023-01-27 Major Shareholding Noti…
Country KR South Korea
Listing KO 195990

About Abpro Bio Co., Ltd.

https://abpro.co/

Abpro Bio Co., Ltd. is a company engaged in the manufacture and sale of precision machine tools. Its primary products include tapping centers, 2-spindle machining centers, and other specialized industrial machinery. In addition to its core manufacturing operations, the company has diversified its business to include a biotechnology division. This division is involved in the development of next-generation antibody therapeutics, often through exclusive development agreements and collaborations with strategic partners.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (insiders/directors) and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-01-27 Korean
불성실공시법인미지정(지정유예)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory announcement from a Korean exchange regarding the status of a company (ABPROBIO) as a 'non-designated' entity for unfair disclosure practices. It details the regulatory decision, the grounds for the decision (KOSDAQ disclosure regulations), and the specific penalty points. Since this is a formal regulatory notice regarding compliance and disclosure status that does not fit into specific financial reporting or corporate action categories, it is classified as a Regulatory Filing (RNS).
2023-01-27 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Abpro Bio) regarding the 'Acquisition of Convertible Bonds before Maturity' (Put Option exercise). This type of filing details changes to the company's capital structure and debt obligations. It does not fit into the specific categories of share issuance (SHA) or general regulatory announcements (RNS) as well as it fits the 'Capital/Financing Update' category, which covers updates on financing activities and capital structure changes.
2023-01-27 Korean
불성실공시법인지정예고(공시번복 1건)
Legal Proceedings Report Classification · 100% confidence The document is a formal notice from the Korea Exchange regarding the designation of the company as a 'non-compliant disclosure corporation' (불성실공시법인) due to a disclosure reversal. This type of regulatory notification regarding legal or compliance status falls under the category of regulatory filings or legal proceedings. Given the specific nature of the regulatory warning and the lack of a better fit for 'legal proceedings' (which usually refers to lawsuits), it is classified as a Regulatory Filing (RNS).
2023-01-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea under the Capital Markets Act. It details the shareholding status of 'Veritas Investment Association' in the company 'ABProBio'. This type of filing is specifically used to notify the market when an entity crosses a significant ownership threshold or changes its shareholding status (in this case, reporting a change in collateral contract terms). In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2022-12-23 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Abipro Bio) regarding a 'Pledge of Shares' (collateral) by the major shareholder. This type of disclosure, which involves changes to financing arrangements and collateralization of shares, falls under the category of capital and financing updates. It is not a report publication announcement, nor is it a director's dealing or share issue, but rather a specific disclosure of a financing-related contract.
2022-12-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.